Czechia – Diagnostic agents – Stanovení přítomnosti sekvenčních variant v genech F2, F5 a MTHFR s výpůjčkou analyzátoru

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal

Deadline not indexed

Check the official notice

Indexed data completeness

86%

Based on seven decision fields

Official title coverage

7 languages

Preserved from source-supplied versions

Classification signal

33694000

Medical equipment, pharmaceuticals and personal care products

90-day market activity

1,060 related notices

117 buyers in Czechia / Health and medical

Buyer activity

49 indexed notices

Published by this buyer in the last 90 days

Market context

How this notice compares with the current market

Biderra found 1,060 health and medical notices from Czechia in its rolling 90-day index. 91% publish an estimated value and 35% include at least one indexed deadline. This notice is not currently active according to the deadline fields available in the source feed.

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

What Biderra adds

For notice 418696-2026, Biderra has normalized the contracting authority country as Czechia, grouped CPV 33694000 under health and medical, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.